These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 28888097)

  • 21. Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII.
    Čapkauskaitė E; Zubrienė A; Smirnov A; Torresan J; Kišonaitė M; Kazokaitė J; Gylytė J; Michailovienė V; Jogaitė V; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2013 Nov; 21(22):6937-47. PubMed ID: 24103428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII.
    Dudutienė V; Zubrienė A; Smirnov A; Gylytė J; Timm D; Manakova E; Gražulis S; Matulis D
    Bioorg Med Chem; 2013 Apr; 21(7):2093-106. PubMed ID: 23394791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition studies of new ureido-substituted sulfonamides incorporating a GABA moiety against human carbonic anhydrase isoforms I-XIV.
    Ceruso M; Antel S; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2014 Dec; 22(24):6768-75. PubMed ID: 25468040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrrolidinone-bearing methylated and halogenated benzenesulfonamides as inhibitors of carbonic anhydrases.
    Vaškevičienė I; Paketurytė V; Pajanok N; Žukauskas Š; Sapijanskaitė B; Kantminienė K; Mickevičius V; Zubrienė A; Matulis D
    Bioorg Med Chem; 2019 Jan; 27(2):322-337. PubMed ID: 30553625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-Sulfamoylphenyl- and N-sulfamoylphenyl-N-thiazolyl-β-alanines and their derivatives as inhibitors of human carbonic anhydrases.
    Vaškevičienė I; Paketurytė V; Zubrienė A; Kantminienė K; Mickevičius V; Matulis D
    Bioorg Chem; 2017 Dec; 75():16-29. PubMed ID: 28888097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects.
    Pastorekova S; Parkkila S; Pastorek J; Supuran CT
    J Enzyme Inhib Med Chem; 2004 Jun; 19(3):199-229. PubMed ID: 15499993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design.
    Linkuvienė V; Zubrienė A; Manakova E; Petrauskas V; Baranauskienė L; Zakšauskas A; Smirnov A; Gražulis S; Ladbury JE; Matulis D
    Q Rev Biophys; 2018 Jan; 51():e10. PubMed ID: 30912486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrases as targets for medicinal chemistry.
    Supuran CT; Scozzafava A
    Bioorg Med Chem; 2007 Jul; 15(13):4336-50. PubMed ID: 17475500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrases as drug targets--an overview.
    Supuran CT
    Curr Top Med Chem; 2007; 7(9):825-33. PubMed ID: 17504127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and inhibition of the recently discovered carbonic anhydrase isoforms CA XIII, XIV and XV.
    Hilvo M; Supuran CT; Parkkila S
    Curr Top Med Chem; 2007; 7(9):893-9. PubMed ID: 17504134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivalent Carbonic Anhydrases Inhibitors.
    Carta F; Dumy P; Supuran CT; Winum JY
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase isozymes in the human pancreas.
    Nishimori I; Onishi S
    Dig Liver Dis; 2001; 33(1):68-74. PubMed ID: 11303978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial carbonic anhydrase VA and VB: properties and roles in health and disease.
    Aspatwar A; Supuran CT; Waheed A; Sly WS; Parkkila S
    J Physiol; 2023 Jan; 601(2):257-274. PubMed ID: 36464834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbonic anhydrase (CA)-related proteins (CA-RPs), and transmembrane proteins with CA or CA-RP domains.
    Tashian RE; Hewett-Emmett D; Carter N; Bergenhem NC
    EXS; 2000; (90):105-20. PubMed ID: 11268511
    [No Abstract]   [Full Text] [Related]  

  • 36. Folding and stability of human carbonic anhydrase II.
    Carlsson U; Jonsson BH
    EXS; 2000; (90):241-59. PubMed ID: 11268519
    [No Abstract]   [Full Text] [Related]  

  • 37. Carbonic anhydrases.
    Deutsch HF
    Int J Biochem; 1987; 19(2):101-13. PubMed ID: 3106115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of carbonic anhydrase II-deficient mice in uncovering the cellular location of membrane-associated isoforms.
    Ridderstråle Y; Wistrand PJ; Holm L; Carter ND
    EXS; 2000; (90):143-55. PubMed ID: 11268514
    [No Abstract]   [Full Text] [Related]  

  • 39. Plant carbonic anhydrases: structure and mechanism.
    Forsman C
    EXS; 2000; (90):519-33. PubMed ID: 11268534
    [No Abstract]   [Full Text] [Related]  

  • 40. Structure and expression of mammalian carbonic anhydrases.
    Edwards Y
    Biochem Soc Trans; 1990 Apr; 18(2):171-5. PubMed ID: 2116334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.